Neumora Therapeutics, Inc. (NMRA) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending September 2025, Neumora Therapeutics, Inc. (NASDAQ:NMRA) is held by 93 institutional firms.

• Neumora Therapeutics saw its institutional ownership percentage fell to 31.3% in September 2025 from 33.3% in June 2025.
• Institutional share ownership changed by -2.45% QoQ, while the number of institutional owners saw a decrease of 10.58% YoY.
• During the quarter, 29 institutions bought more Neumora Therapeutics shares, 42 sold shares, and 22 of the 93 total investors held their position steady.
• The aggregate institutional position in Neumora Therapeutics now stands at 50.75Mn shares as of September 2025, after investors decreased their holdings (down by 1.28Mn shares quarter on quarter which is down 18.32Mn shares year over year).
• As of September 30, 2025, SOFTBANK GROUP CORP. held Neumora Therapeutics's largest shareholding position with over 6.54Mn shares, representing 4.04% of total outstanding shares.
• Among the most significant buyers of Neumora Therapeutics during September 2025 were MIC Capital Management UK LLP (2.23Mn), JACOBS LEVY EQUITY MANAGEMENT, INC (830.82K), MILLENNIUM MANAGEMENT LLC (776.86K), AlphaCore Capital LLC (301.02K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (153.47K).
• Leading sellers of Neumora Therapeutics stock in September 2025 included BlackRock, Inc. (1.07Mn), GSA CAPITAL PARTNERS LLP (795.33K), VANGUARD GROUP INC (713.74K), AQR CAPITAL MANAGEMENT LLC (568.41K), UBS Group AG (521.66K).
• The top 10 institutional holders of Neumora Therapeutics for the quarter ending September 2025 included SOFTBANK GROUP CORP. (6.54Mn), MIC Capital Management UK LLP (4.46Mn), Siren, L.L.C. (4.36Mn), VANGUARD GROUP INC (4.05Mn), FMR LLC (3.50Mn), WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST (3.31Mn), ICONIQ Capital, LLC (2.56Mn), Lunate Capital Ltd (2.12Mn), MILLENNIUM MANAGEMENT LLC (2.01Mn), T. Rowe Price Investment Management, Inc. (1.94Mn).